GlaxoSmithKline Executive Prevented from Leaving China

Article/ Pub

Washington Post

July 17, 2013

By Katerina Sokou

China has stepped up its anti-corruption campaign against GlaxoSmithKline, blocking a senior executive of one of the world’s largest pharmaceutical companies from leaving the country...

Preventing a foreign executive from leaving the country is bound to create a stir among Western companies, some analysts said.

“Whether it is going to create a problem for the expatriates who live in China, certainly it will have a negative impact, but I do not think it will be dramatic,” said Siva Yam, president of the United States of America-China Chamber of Commerce.

But he noted: “It does not matter if they are foreign or Chinese, if they have committed a crime based on the local law then they have a problem.”

Related Topics

21st Annual U.S.-China Trade Conference
“Managing the Uncertainties:
Lessons Learned from Supply Chain Disruptions,”

May 12-13, 2022

U.S.-China Chamber of Commerce

Passport renewal via mail in China

February 16, 2022

U.S.-China Chamber of Commerce

China Travel Tips: December 2021

December 26, 2021

U.S.-China Chamber of Commerce

New travel requirements for all passengers entering United States. Negative COVID test within 24 hours of departure.

December 4, 2021

U.S.-China Chamber of Commerce